Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Atractylodin is a polyethylene alkyne that has been found in A. lancea and has diverse biological activities.1,2,3,4 It inhibits N-acylethanolamine acid amidase (NAAA; IC50 = 2.81 µM for the human enzyme) and increases levels of the endocannabinoids palmitoyl ethanolamide (Item No. 90350) and oleoyl ethanolamide (Item No. 90265) in LPS-stimulated BV-2 microglial cells when used at a concentration of 10 µM.1 Atractylodin is cytotoxic to CL-6 and HuCC-T1 cholangiocarcinoma cells (IC50s = 41.66 and 38.78 µM, respectively).2 Atractylodin (10 mg/kg) increases the gastric emptying rate in mice, an effect that can be blocked by the growth hormone secretagogue receptor (GHS-R) antagonist (D-Lys3)-GHRP-6 (Item No. 36862).3 It decreases pulmonary edema in a mouse model of LPS-induced acute lung injury when administered at doses of 40 and 80 mg/kg.4
WARNING This product is not for human or veterinary use.
1. Natural potent NAAA inhibitor atractylodin counteracts LPS-
2. Cytotoxic activities and effects of atractylodin and β-
3. Atractylodin induces myosin light chain phosphorylation and promotes gastric emptying through ghrelin receptor. Evid. Based Complement. Alternat. Med. 2186798 (2017).
4. Atractylodin attenuates lipopolysaccharide-